- Home
- ERIE vs ICLR Comparison
ERIE vs ICLR Comparison
Compare ERIE & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ERIE | ICLR |
|---|---|---|
| Founded | 1925 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 13.1B |
| IPO Year | 2012 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ERIE | ICLR |
|---|---|---|
| Price | $222.24 | $168.91 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $178.62 |
| AVG Volume (30 Days) | 142.2K | ★ 958.5K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 491.00 | N/A |
| Revenue | ★ $1,691,774,000.00 | N/A |
| Revenue This Year | $6.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $0.45 | $12.91 |
| Revenue Growth | ★ 5.96 | N/A |
| 52 Week Low | $204.63 | $66.57 |
| 52 Week High | $330.54 | $203.91 |
Technical Indicators
Market Signals| Indicator | ERIE | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 31.96 | 53.52 |
| Support Level | $208.10 | $162.32 |
| Resistance Level | $231.76 | $181.71 |
| Average True Range (ATR) | 6.61 | 6.84 |
| MACD | -2.90 | 0.63 |
| Stochastic Oscillator | 9.70 | 72.07 |
Price Performance
Historical ComparisonAbout ERIE Erie Indemnity Company
Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.
About ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.